Literature DB >> 26309580

Expression of bone morphogenetic protein 2 in rabbit radial defect site with different lengths.

Guo-Zhu Hou1, Feng Xu2, Wen-Ju Li3, Xiao-Meng Zhu4, Xing-Hua Song5, Yu-Lin Zhan6.   

Abstract

BACKGROUND: It has been studied that the distribution of bone morphogenetic protein 2 is regular under bone defect situation.
OBJECTIVE: To observe the expression of bone morphogenetic protein 2 in rabbit radial defect site with different lengths.
METHODS: Forty-eight New Zealand rabbits were divided into two groups randomly. 0.5 cm bone defect and 3.0 cm bone defect were made by wire saw at the middle part of radius bone after anaesthesia. RESULTS AND
CONCLUSIONS: Western blot results showed that in the 0.5 cm bone defect group, the expression of bone morphogenetic protein 2 of the tissues in the bone defect site was increased gradually at 1, 3, 4 weeks after operation, and the expression in each defect group was increased when compared with that immediately after injury (P<0.05). In the 3.0 cm bone defect group, the expression of bone morphogenetic protein 2 of tissues in bone defect site was increased gradually and reached to its peak at 3 weeks after the operation (P<0.05). The peak value in the 3.0 cm bone defect group was significantly higher than that in 0.5 cm bone defect group (P<0.05). The peak value was maintained in high level. The comparison of bone callus formation showed that the bone callus formation of 3.0 cm bone defect group was less than that of the 0.5 cm bone defect group at 3 and 4 weeks after operation (P<0.05). The results indicate that expression of the bone morphogenetic protein 2 in 3.0 cm bone defect site is increased significantly, but the expression level cannot make the bone defect heal itself.

Entities:  

Keywords:  Tissue construction; bone defect; bone healing; bone length; bone tissue construction; rabbit

Year:  2015        PMID: 26309580      PMCID: PMC4537957     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

Review 1.  Clinical applications of bone graft substitutes.

Authors:  S N Khan; E Tomin; J M Lane
Journal:  Orthop Clin North Am       Date:  2000-07       Impact factor: 2.472

2.  Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation.

Authors:  Björn Behr; Chad Tang; Günter Germann; Michael T Longaker; Natalina Quarto
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

3.  Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.

Authors:  M Raida; A C Heymann; C Günther; D Niederwieser
Journal:  Int J Mol Med       Date:  2006-10       Impact factor: 4.101

4.  Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector.

Authors:  Hajime Tsuda; Takuro Wada; Yoshinori Ito; Hiroaki Uchida; Hironari Dehari; Kiminori Nakamura; Katsunori Sasaki; Masayoshi Kobune; Toshihiko Yamashita; Hirofumi Hamada
Journal:  Mol Ther       Date:  2003-03       Impact factor: 11.454

5.  Repair of canine mandibular bone defects with bone marrow stromal cells and porous beta-tricalcium phosphate.

Authors:  Jie Yuan; Lei Cui; Wen Jie Zhang; Wei Liu; Yilin Cao
Journal:  Biomaterials       Date:  2006-11-07       Impact factor: 12.479

6.  Adipose-derived adult stromal cells heal critical-size mouse calvarial defects.

Authors:  Catherine M Cowan; Yun-Ying Shi; Oliver O Aalami; Yu-Fen Chou; Carina Mari; Romy Thomas; Natalina Quarto; Christopher H Contag; Benjamin Wu; Michael T Longaker
Journal:  Nat Biotechnol       Date:  2004-04-11       Impact factor: 54.908

Review 7.  Bone remodeling during fracture repair: The cellular picture.

Authors:  Aaron Schindeler; Michelle M McDonald; Paul Bokko; David G Little
Journal:  Semin Cell Dev Biol       Date:  2008-07-25       Impact factor: 7.727

8.  Role of the N- and C-terminal fragments of parathyroid-hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment.

Authors:  Luís Fernándes de Castro; Daniel Lozano; Sonia Dapía; Sergio Portal-Núñez; José R Caeiro; Enrique Gómez-Barrena; Pedro Esbrit
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

9.  Cytokine-like 1 (Cytl1) regulates the chondrogenesis of mesenchymal cells.

Authors:  Jae-Sung Kim; Zae Young Ryoo; Jang-Soo Chun
Journal:  J Biol Chem       Date:  2007-07-20       Impact factor: 5.157

10.  Increased serum OPG in atrophic nonunion shaft fractures.

Authors:  Daniele Marchelli; Luca P Piodi; Costantino Corradini; Luca Parravicini; Cesare Verdoia; Fabio M Ulivieri
Journal:  J Orthop Traumatol       Date:  2009-03-19
View more
  2 in total

1.  Restoration of bone defects using modified heterogeneous deproteinized bone seeded with bone marrow mesenchymal stem cells.

Authors:  Jun Li; Zeyu Huang; Liyan Chen; Xin Tang; Yue Fang; Lei Liu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

2.  Orthogonal test design for the optimization of superparamagnetic chitosan plasmid gelatin microspheres that promote vascularization of artificial bone.

Authors:  Chen Tao; Xie Lina; Wang Changxuan; Luo Cong; Yang Xiaolan; Huang Tao; An Hong
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-10-12       Impact factor: 3.368

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.